HRP20150387T1 - Sol kolina i trometamina od likofelona - Google Patents

Sol kolina i trometamina od likofelona Download PDF

Info

Publication number
HRP20150387T1
HRP20150387T1 HRP20150387TT HRP20150387T HRP20150387T1 HR P20150387 T1 HRP20150387 T1 HR P20150387T1 HR P20150387T T HRP20150387T T HR P20150387TT HR P20150387 T HRP20150387 T HR P20150387T HR P20150387 T1 HRP20150387 T1 HR P20150387T1
Authority
HR
Croatia
Prior art keywords
choline
licofelone
salt
tromethamine salt
treatment
Prior art date
Application number
HRP20150387TT
Other languages
English (en)
Inventor
Wolfgang Albrecht
Hans-Günter Striegel
Stefan Laufer
Original Assignee
C-A-I-R Biosciences Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C-A-I-R Biosciences Gmbh filed Critical C-A-I-R Biosciences Gmbh
Publication of HRP20150387T1 publication Critical patent/HRP20150387T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (4)

1. Spoj, naznačen time, da je to 6-(4-klorofenil)-2,2-dimetil-7-fenil-2,3-dihidro-1H- pirolizin-5-il-octena kiselina-kolinska sol formule I: [image]
2. Farmaceutski sastav, naznačen time, da obuhvaća sol iz zahtjeva 1 ijedno ili više farmaceutski prihvatljivih pomoćnih sredstava.
3. Uporaba soli prema zahtjevu 1, naznačena time, da je za proizvodnju lijeka za liječenje reumatoidne bolesti.
4. Sol prema zahtjevu 1, naznačena time, da se upotrebljava u liječenju reumatoidne bolesti.
HRP20150387TT 2008-10-31 2015-04-03 Sol kolina i trometamina od likofelona HRP20150387T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08168127 2008-10-31
EP09744401.2A EP2350082B1 (en) 2008-10-31 2009-10-30 Choline and tromethamine salt of licofelone
PCT/EP2009/064390 WO2010049525A1 (en) 2008-10-31 2009-10-30 Choline and tromethamine salt of licofelone

Publications (1)

Publication Number Publication Date
HRP20150387T1 true HRP20150387T1 (hr) 2015-06-05

Family

ID=41376293

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150387TT HRP20150387T1 (hr) 2008-10-31 2015-04-03 Sol kolina i trometamina od likofelona

Country Status (20)

Country Link
US (1) US8519155B2 (hr)
EP (1) EP2350082B1 (hr)
JP (1) JP5628816B2 (hr)
KR (1) KR101688238B1 (hr)
CN (1) CN102264741B (hr)
AU (1) AU2009309575B2 (hr)
BR (1) BRPI0920300A2 (hr)
CA (1) CA2741941C (hr)
CY (1) CY1116205T1 (hr)
DK (1) DK2350082T3 (hr)
ES (1) ES2534772T3 (hr)
HR (1) HRP20150387T1 (hr)
MX (1) MX2011004298A (hr)
NZ (1) NZ592378A (hr)
PL (1) PL2350082T3 (hr)
PT (1) PT2350082E (hr)
SI (1) SI2350082T1 (hr)
SM (1) SMT201500105B (hr)
WO (1) WO2010049525A1 (hr)
ZA (1) ZA201103911B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10206904B2 (en) 2015-07-17 2019-02-19 The Board Of Regents Of The University Of Oklahoma Licofelone derivatives and methods of use
EP3593792A1 (de) * 2018-07-11 2020-01-15 Welding GmbH & Co. KG Pharmazeutische zusammensetzung umfassend 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäurecholinsalz
WO2023089636A1 (en) * 2021-11-21 2023-05-25 Aizant Drug Research Solutions Private Limited Pharmaceutical compositions of licofelone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250636B (it) 1991-07-04 1995-04-21 Ricerche Di Schiena Del Dr Mic Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
ES2058024B1 (es) * 1992-11-10 1995-05-01 Menarini Lab Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
IT1290448B1 (it) * 1997-04-01 1998-12-03 Schiena Michele Giuseppe Di Nimesulide sale di colina,metodo di preparazione e composizioni farmaceutiche che lo contengono
JP5143326B2 (ja) * 2000-01-28 2013-02-13 メルクル・ゲーエムベーハー 6−(4−クロロフェニル)−2,2−ジメチル−7−フェニル−2,3−ジヒドロ−1h−ピロリジン−5−イル酢酸の製造法
BR0212244A (pt) * 2001-08-30 2004-10-05 Merckle Gmbh Uso de um ou mais do que um composto e seus isÈmeros ópticos, derivados e sais fisiologicamente aceitáveis, composição farmacêutica, e, método de tratamento ou de prevenção da degeneração ou da destruição de cartilagem articular e/ou de osso subcondral em uma ou mais articulações de um mamìfero
BR0310068A (pt) * 2002-05-17 2005-03-08 Merckle Gmbh Uso de um ou mais de um composto, combinação, e, composição farmacêutica
WO2006083687A1 (en) * 2005-01-28 2006-08-10 Cardiome Pharma Corp. Crystal salt of xanthine oxidase inhibitors
TW200726755A (en) * 2005-07-07 2007-07-16 Astellas Pharma Inc A crystalline choline salt of an azulene derivative
CN101228171A (zh) * 2005-07-26 2008-07-23 默克勒有限公司 作为5-脂氧化酶和环加氧酶抑制剂的吡咯里嗪和中氮茚化合物的大环内酯偶联物
WO2007015724A1 (en) * 2005-08-01 2007-02-08 Mallinckrodt Baker, Inc. Tromethamine salt of valproic acid
GB0603522D0 (en) * 2006-02-22 2006-04-05 Avidex Ltd Kinase inhibition
EP1884239A1 (en) * 2006-07-28 2008-02-06 Merckle Gmbh Annellated pyrrole compounds for cancer management

Also Published As

Publication number Publication date
CA2741941A1 (en) 2010-05-06
US20120010261A1 (en) 2012-01-12
AU2009309575A1 (en) 2010-05-06
PL2350082T3 (pl) 2015-08-31
SI2350082T1 (sl) 2015-05-29
ES2534772T3 (es) 2015-04-28
US8519155B2 (en) 2013-08-27
EP2350082B1 (en) 2015-01-14
ZA201103911B (en) 2012-02-29
JP5628816B2 (ja) 2014-11-19
BRPI0920300A2 (pt) 2020-08-11
CY1116205T1 (el) 2017-02-08
KR20110126582A (ko) 2011-11-23
CN102264741B (zh) 2014-07-16
NZ592378A (en) 2012-09-28
KR101688238B1 (ko) 2016-12-20
JP2012506899A (ja) 2012-03-22
WO2010049525A1 (en) 2010-05-06
CA2741941C (en) 2016-09-06
PT2350082E (pt) 2015-04-30
SMT201500105B (it) 2015-07-09
MX2011004298A (es) 2011-10-21
EP2350082A1 (en) 2011-08-03
AU2009309575B2 (en) 2015-02-26
CN102264741A (zh) 2011-11-30
DK2350082T3 (en) 2015-04-20

Similar Documents

Publication Publication Date Title
HRP20170624T1 (hr) Derivat piridina i pirazina za liječenje kronične opstrukcijske plućne bolesti
CA2918938C (en) Substituted aminopyrimidine compounds and methods of use
HRP20201243T1 (hr) N-piperidinil acetamidni derivati kao blokatori kalcijevog kanala
HRP20150770T1 (hr) Terapijska kombinacija koja sadrži dolutegravir, abakavir i lamivudin
HRP20171512T1 (hr) Derivati betulina
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
HRP20120803T1 (hr) Prolijekovi alkilatora fosforamidata
JP2013520405A5 (hr)
HRP20160135T1 (hr) Derivati 2-(2,4,5-supstituiranog-anilino) pirimidina kao modulatori egfr koji su korisni za lijeäśenje raka
HRP20150119T1 (hr) N-supstituirani derivati glicina kao inhibitori hidroksilaze
JP2013542247A5 (hr)
HRP20221304T1 (hr) Kombinacija koja sadrži inhibitor mek i inhibitor b-raf
BR122019027412B8 (pt) composição farmacêutica de liberação sustentada na forma de micropartículas, processo para preparação das ditas micropartículas, e kit de administração
EA202091303A3 (ru) Композиция ингибитора jak для местного применения
EA201270505A1 (ru) Производные иминотиадиазиндиоксида в качестве ингибиторов bace, композиции на их основе, и их применение
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
HRP20161389T1 (hr) Derivati pantotenata namijenjeni liječenju neuroloških poremećaja
HRP20150387T1 (hr) Sol kolina i trometamina od likofelona
HRP20201187T1 (hr) Derivat triazolopirazinona koristan kao inhibitor ljudskog pde1
EA201270653A1 (ru) Антагонист dpи его применение
HRP20151340T1 (hr) Derivati tieno[2,3-d] pirimidina i njihova primjena u lijeäśenju aritmije
HRP20180537T1 (hr) Uporaba agomelatina za pripravu lijekova za liječenje opsesivno-kompulzivnog poremećaja (ocd)
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
SI2914599T1 (en) The solid salt form as alpha-6-mPEG6-O-hydroxycodone as opioid agonists and its use